Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.14% Nasdaq Up0.86%

Pfizer Inc. (PFE)

-NYSE

30.93 Down 0.13(0.42%) Apr 22, 4:00PM EDT|After Hours : 30.95 Up 0.02 (0.06%) Apr 22, 7:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 58,986,000   65,259,000   65,165,000  
Cost of Revenue11,334,000  14,076,000  14,788,000  
Gross Profit 47,652,000   51,183,000   50,377,000  
Operating Expenses
Research Development7,870,000  9,074,000  9,483,000  
Selling General and Administrative16,616,000  18,832,000  18,973,000  
Non Recurring1,880,000  2,930,000  3,145,000  
Others5,175,000  5,544,000  5,364,000  
Total Operating Expenses31,541,000  36,380,000  36,965,000  
Operating Income or Loss 16,111,000   14,803,000   13,412,000  
Income from Continuing Operations
Total Other Income/Expenses Net(4,031,000)(2,499,000)(3,941,000)
Earnings Before Interest And Taxes12,080,000  12,304,000  9,471,000  
Interest Expense -   -   -  
Income Before Tax12,080,000  12,304,000  9,471,000  
Income Tax Expense2,562,000  3,909,000  1,153,000  
Minority Interest(28,000)(40,000)(31,000)
Net Income From Continuing Ops9,518,000  8,395,000  8,318,000  
Non-recurring Events
Discontinued Operations5,080,000  1,654,000  (30,000)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 14,570,000   10,009,000   8,257,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 14,570,000   10,009,000   8,257,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.